These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19376230)

  • 1. The role of PPARs in modulating cardiac metabolism in diabetes.
    Holness MJ; Samsuddin S; Sugden MC
    Pharmacol Res; 2009 Sep; 60(3):185-94. PubMed ID: 19376230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes].
    Kravchenko NA; Iarmysh NV
    Tsitol Genet; 2011; 45(3):68-78. PubMed ID: 21774406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B; Dembińska-Kieć A; Olszanecka A; Bodzioch M; Kawecka-Jaszcz K
    J Physiol Pharmacol; 2005 Jun; 56(2):149-62. PubMed ID: 15985699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
    Yahia RB; Lichnovská R; Brychta T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PPAR and diabetes].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2005 Apr; 63(4):623-9. PubMed ID: 15828230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy.
    Lee TI; Kao YH; Chen YC; Huang JH; Hsiao FC; Chen YJ
    Diabetes Res Clin Pract; 2013 Jun; 100(3):330-9. PubMed ID: 23369225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus.
    Viana Abranches M; Esteves de Oliveira FC; Bressan J
    Nutr Hosp; 2011; 26(2):271-9. PubMed ID: 21666962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARs and the orchestration of metabolic fuel selection.
    Sugden MC; Zariwala MG; Holness MJ
    Pharmacol Res; 2009 Sep; 60(3):141-50. PubMed ID: 19646653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs: fatty acid sensors controlling metabolism.
    Poulsen Ll; Siersbæk M; Mandrup S
    Semin Cell Dev Biol; 2012 Aug; 23(6):631-9. PubMed ID: 22273692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives.
    Grimaldi PA
    Cell Mol Life Sci; 2007 Oct; 64(19-20):2459-64. PubMed ID: 17876521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in PPARs research--basic and clinical aspects].
    Kadowaki T
    Nihon Rinsho; 2005 Apr; 63(4):539-48. PubMed ID: 15828218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARs-Orchestrated Metabolic Homeostasis in the Adipose Tissue.
    Sun C; Mao S; Chen S; Zhang W; Liu C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
    Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
    Chinetti-Gbaguidi G; Fruchart JC; Staels B
    Curr Opin Pharmacol; 2005 Apr; 5(2):177-83. PubMed ID: 15780828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the development of new PPAR agonists in diabetes.
    Cavender MA; Nicholls SJ; Lincoff AM
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S32-7. PubMed ID: 20489419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
    Feige JN; Gelman L; Michalik L; Desvergne B; Wahli W
    Prog Lipid Res; 2006 Mar; 45(2):120-59. PubMed ID: 16476485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphisms of PPARs and metabolic disorders].
    Araki E; Igata M; Motoshima H; Tsuruzoe K
    Nihon Rinsho; 2005 Apr; 63(4):617-22. PubMed ID: 15828229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.